Clinical Trials Sponsored by Arco Foundation

Total 15835 results

University Hospital Inselspital, Berne
Arco Foundation

Completed

Effect of Transcutaneous Electrostimulation (TENS) on Pain and Physical Function in Patients With Knee Osteoarthritis (ETRELKA)

Osteoarthritis, Knee

Switzerland
UNICANCER
Fondation ARC

Active, not recruiting

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists (CHECK'UP)

Melanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

France
UNICANCER
Novartis; Fondation ARC

Completed

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor (SAFIR-TOR)

Metastatic Breast Cancer

France
UNICANCER
AstraZeneca; Fondation ARC

Active, not recruiting

SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer (SAFIR02_Breast)

Metastatic Breast Cancer

France
Lymphoma Study Association
Fondation ARC

Terminated

R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Switzerland, Belgium
Lymphoma Study Association
Fondation ARC

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Belgium
Institut Claudius Regaud
Fondation ARC

Recruiting

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 (SAMHY2)

Leiomyosarcoma

France
Barco NV

Completed

Development and Validation of a New Digital Dermatoscope in the United States

Skin Cancer

United States
Arno Therapeutics

Unknown

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy

France
Arno Therapeutics

Unknown

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Glioblastoma Multiforme | Gliosarcoma | GBM

United States, Canada
Arno Therapeutics

Unknown

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

United States
Arno Therapeutics

Completed

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Lymphoma | Solid Tumors

United States, United Kingdom
Institut Cancerologie de l'Ouest
Fondation ARC

Active, not recruiting

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Rectal Cancer

France
UNICANCER
Clovis Oncology, Inc.; Fondation ARC

Completed

A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature (RUBY)

Metastatic Breast Cancer

France
IHU Strasbourg
ARC Foundation for Cancer Research

Withdrawn

Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen)

Colorectal Cancer
Barco NV

Recruiting

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer (DermScan)

Skin Diseases | Skin Cancer

Belgium
Arch Oncology

Completed

Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
ARCH Therapuetics

Completed

Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions

Skin Neoplasms

Ireland
Arch Therapeutics

Recruiting

Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

Diabetic Foot Ulcer | Non-healing Wound

United States
Barco NV

Terminated

Utility of Digital Dermoscopy in the Skin Cancer Clinic

Skin Cancer | Dermatology/Skin - Other

United Kingdom
Arno Therapeutics

Unknown

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Recurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate Cancer

United Kingdom
Eremo Hospital, Arco
University of Padova

Completed

Robot-assisted Rehabilitation of the Upper Limb in Acute and Subacute Post-stroke Patients

Stroke | Cerebrovascular Accident | Upper Extremity Paresis

Italy
IHU Strasbourg
ARC Foundation for Cancer Research

Terminated

Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment (iEXMachyna3)

Parathyroid Diseases | Thyroid Diseases | Liver Metastases | Liver Cancer | Digestive Cancer | Digestive Perfusion

France
Arch Biopartners Inc.

Completed

A Phase I Study to Evaluate LSALT Peptide

None - Study is to Determine Safety in Healthy Participants

Australia
Pappagallo, Marco, M.D.

Completed

A Pilot Trial of IV Pamidronate for Low Back Pain

Chronic Low Back Pain

United States
ARCA Biopharma, Inc.

Completed

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters

Thrombosis | Venous Thrombosis | Catheter Occlusion

United States
ARCA Biopharma, Inc.

Completed

Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters

Thrombosis | Venous Thrombosis

United States
Centre Leon Berard
Janssen, LP; Fondation ARC

Recruiting

A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer (ABLE02)

Metastatic Breast Cancer

France
Marco Pacchioni

Not yet recruiting

Evaluation of the Antalgic Effect of Puressentiel Joints and Muscles - Gel on Joint Pain of the Knee (EVAPURGEL)

Pain | Joint Pain

France
ARCA Biopharma, Inc.

Completed

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

Catheters, Indwelling

United States
ARCA Biopharma, Inc.

Suspended

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Colon Cancer

United States
ARCA Biopharma, Inc.

Terminated

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Acute Ischemic Stroke

United States, Canada
ARCA Biopharma, Inc.

Completed

Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

Arterial Occlusive Diseases

United States
Aro Biotherapeutics

Recruiting

Study to Assess the Safety, Tolerability, PK and PD of ABX1100

Healthy

Canada
ARO Medical

Unknown

Safety Study of ARO Spinal System as an Adjunct to Lumbar Decompression

Lumbar Disc Prolapse With Radiculopathy

Denmark
Arch Biopartners Inc.

Recruiting

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Acute Kidney Injury | Cardiac Surgery

Canada, Turkey
Arch Biopartners Inc.

Completed

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Severe Acute Respiratory Syndrome | Acute Kidney Injury | COVID | Acute Respiratory Distress Syndrome | Sars-CoV2

United States, Turkey, Canada
ARCA Biopharma, Inc.

Unknown

Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery (SNAP-CABG-OFF)

Heart Disease
ARCA Biopharma, Inc.

Terminated

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Arterial Occlusive Diseases

United States
Fondazione Edmund Mach
Casa di Cura Eremo di Arco (TN) Italy; OlioCRU Consorzio srl Arco (TN) Italy

Completed

Measuring the Impact of Dietary Supplementation With a New Baking Product on Gut Microbiota and Cholesterol Metabolism

Hypercholesterolemia

Italy
UNICANCER
Pfizer; National Cancer Institute, France; Fondation ARC

Completed

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 (AcSé)

Metastatic Cancer | Solid Tumors | Hematologic Cancers

France
ARC Devices

Withdrawn

Comparison of Thermometry in Canada for Pediatrics (CIT-CRCP)

Healthy | Febrile Illness

Canada
Institut Curie
National Cancer Institute, France; Fondation ARC

Terminated

PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)

Acute Myeloid Leukemia, in Relapse | Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome | de Novo Acute Myeloid Leukemia at Diagnostic

France
Arjo AB
Loughborough University

Enrolling by invitation

A Comparison Study of the Maxi Move 5 (MM5) Device

Healthy Volunteers

United Kingdom
ARCA Biopharma, Inc.
Medtronic

Completed

Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure (GENETIC-AF)

Current or Recent History of Atrial Fibrillation

United States, Canada, Hungary, Netherlands, Poland, Serbia
Cameroon Resuscitation Council
ARCV

Unknown

Epidemiology of Sudden Death in Cameroon (DOUALA-SD)

Cardiovascular Diseases

Cameroon
Arno Therapeutics
University of Kentucky; Arch Medical Services Inc., DBA The Center for Cancer...

Completed

Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

Tumors

United States
UNICANCER
Merck Sharp & Dohme LLC; Fondation ARC; ERA-NET

Active, not recruiting

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (PEVOsq)

Vulvar Cancer | Cervix Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Penile Cancer | Squamous Cell Lung Cancer

France
Worldwide Innovative Network Association
Pfizer; ARC Foundation for Cancer Research

Terminated

Survival Prolongation by Rationale Innovative Genomics (SPRING)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB

Israel, United States, Luxembourg, Spain
Argo Sante
GenSight Biologics

Completed

Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection

Leber's Hereditary Optic Neuropathy (LHON)

France

Clinical Trials Sponsored by Arco Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations